{"id":"W7108607412","doi":"10.1182/blood-2025-5117","title":"Efficacy of single-agent subcutaneous blinatumomab in adults with relapsed/refractory (R/R) B-cell acute lymphoblastic leukemia (B-ALL): Results from a phase 1/2 dose expansion study with extended follow-up","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Calgary","funders":"","keywords":"Blinatumomab; Clinical endpoint; Phases of clinical research; Pharmacokinetics; Refractory (planetary science); Minimal residual disease; Hematopoietic stem cell transplantation; Adverse effect; Acute lymphocytic leukemia","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001616089,0.0006645825,0.001139391,0.0002682226,0.0002602549,0.0006569989,0.0005139903,0.0005599009,0.001453261],"category_scores_gemma":[0.000642398,0.0002928815,0.0008114719,0.0003447087,0.0004033596,0.0005618845,0.0002464757,0.001731887,0.0005427662],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005787858,"about_ca_system_score_gemma":0.0006824034,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005821422,"about_ca_topic_score_gemma":0.001180506,"domain_scores_codex":[0.9996511,0.0001414883,0.00002913242,0.00007095607,0.00005549835,0.00005184211],"domain_scores_gemma":[0.999451,0.0000917375,0.0001778324,0.00006332016,0.00004874758,0.0001673561],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.3415123,0.05373061,0.0738533,0.001569696,0.002917745,0.0006015828,0.0008746269,0.004415635,0.1220892,0.0002401312,0.00722598,0.3909692],"study_design_scores_gemma":[0.163374,0.6422556,0.1637917,0.0001150458,0.002099809,0.001512835,0.0001790597,0.002093673,0.0166764,0.0002000697,0.007640871,0.00006095308],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9957695,0.002263526,0.0002678647,0.0001467036,0.00002100565,0.0003083339,0.0005390432,0.00005638359,0.0006276215],"genre_scores_gemma":[0.9954565,0.001221219,0.000635797,0.0002973607,0.00004219934,0.0003413047,0.001399567,0.00001442943,0.0005915952],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001616089,"threshold_uncertainty_score":0.008546829,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01249365380454261,"score_gpt":0.2721165397817107,"score_spread":0.2596228859771681,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}